Nicotine consumption is regulated by a human polymorphism in dopamine neurons
Open accessAbstract
Smoking is the most important preventable cause of morbidity and mortality worldwide. Recent genome-wide association studies highlighted a human haplotype on chromosome 15 underlying the risk for tobacco dependence and lung cancer. Several polymorphisms in the CHRNA3-CHRNA5-CHRNB4 cluster coding for the nicotinic acetylcholine receptor (nAChR) α3, α5 and β4 subunits were implicated. In mouse models, we define a key role in the control of sensitivity to nicotine for the α5 subunit in dopaminergic (DAergic) neurons of the ventral tegmental area (VTA). We first investigated the reinforcing effects of nicotine in drug-naive α5(-/-) mice using an acute intravenous nicotine self-administration task and ex vivo and in vivo electrophysiological recordings of nicotine-elicited DA cell activation. We designed lentiviral re-expression vectors to achieve targeted re-expression of wild-type or mutant α5 in the VTA, in general, or in DA neurons exclusively. Our results establish a crucial role for α5*-nAChRs in DAergic neurons. These receptors are key regulators that determine the minimum nicotine dose necessary for DA cell activation and thus nicotine reinforcement. Finally, we demonstrate that a single-nucleotide polymorphism, the non-synonymous α5 variant rs16969968, frequent in many human populations, exhibits a partial loss of function of the protein in vivo. This leads to increased nicotine consumption in the self-administration paradigm. We thus define a critical link between a human predisposition marker, its expression in DA neurons and nicotine intake.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The impact of the mutation defining the risk allele has been validated repeatedly in vitro and in animal models.
“The impact of the mutation that defines the risk allele has been validated repeatedly in vitro and in animal models (Kuryatov et al. 2011; Morel et al. 2014).”
From Nicotine Withdrawal (2015) · cites this paper as Morel et al. 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · see citing works
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics
Benowitz, N. L. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094742 · Cited by 979 · see citing works
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · see citing works
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · see citing works
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · see citing works
Self-citationSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · see citing works
Kuryatov, A., Berrettini, W., & Lindstrom, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.066357 · Cited by 171 · see citing works
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159 · see citing works
Flagged first, then by citations
Research works printed but not linked: 32
- [3]Salas R, Pieri F, De Biasi M. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci 2004; 24: 10035– 10039. 15537871 PMC6730195
- [4]Wang JC, Cruchaga C, Saccone NL, Bertelsen S, Liu P, Budde JP Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 2009; 18: 3125– 3135. 19443489 PMC2714722
- [5]Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008; 165: 1163– 1171. 18519524 PMC2574742
- [6]Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 2009; 78: 703– 711. 19481063
- [7]Klink R, de Kerchove d’Exaerde A, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 2001; 21: 1452– 1463. 11222635 PMC6762941
- [8]Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011; 471: 597– 601. 21278726 PMC3079537
- [9]Chatterjee S, Santos N, Holgate J, Haass-Koffler CL, Hopf FW, Kharazia V The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area. PLoS ONE 2013; 8: e68300. 23869214 PMC3712017
- [10]Tuesta LM, Fowler CD, Kenny PJ. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 2011; 82: 984– 995. 21740894 PMC3163076
- [12]Di Ciano P, Everitt BJ. Contribution of the ventral tegmental area to cocaine-seeking maintained by a drug-paired conditioned stimulus in rats. Eur J Neurosci 2004; 19: 1661– 1667. 15066162
- [13]Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255– 257. 8717040
- [14]Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Mol Psychiatry 2012; 18: 382– 393. 22751493
- [15]Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 2003; 63: 1059– 1066. 12695534
- [16]Martellotta MC, Kuzmin A, Zvartau E, Cossu G, Gessa GL, Fratta W. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 1995; 52: 271– 274. 8577790
- [17]Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 2008; 28: 12318– 12327. 19020025 PMC2819191
- [18]Marti F, Arib O, Morel C, Dufresne V, Maskos U, Corringer P-J Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.. Neuropsychopharmacology 2011; 36: 2244– 2257. 21716264 PMC3176561
- [22]Tolu S, Avale ME, Nakatani H, Pons S, Parnaudeau S, Tronche F A versatile system for the neuronal subtype specific expression of lentiviral vectors. FASEB J 2010; 24: 723– 730. 19858094
- [23]Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984; 4: 2877– 2890. 6150071 PMC6564720
- [24]Grace AA, Bunney BS.. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 1984; 4: 2866– 2876. 6150070 PMC6564731
- [26]Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009; 89: 73– 120. 19126755 PMC2713585
- [28]Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 2008; 325: 302– 312. 18184829 PMC3821841
- [29]Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA The role of alpha5 nicotinic acetylcholine receptors in the pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther 2010; 334: 137– 146. 20400469 PMC2912049
- [30]Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux J-P Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 2006; 50: 911– 921. 16772172
- [31]Tsuneki H, Klink R, Léna C, Korn H, Changeux JP. Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci 2000; 12: 2475– 2485. 10947823
- [32]Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature 1996; 380: 347– 351. 8598930
- [33]Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998; 391: 173– 177. 9428762
- [34]Fowler CD, Tuesta L, Kenny PJ. Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice. Psychopharmacology 2013; 229: 503– 513. PMC3930613 23958943
- [35]Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S Aversion to Nicotine Is Regulated by the Balanced Activity of beta4 and alpha5 Nicotinic Receptor Subunits in the Medial Habenula. Neuron 2011; 70: 522– 535. 21555077
- [36]Scholze P, Koth G, Orr-Urtreger A, Huck S. Subunit composition of α5-containing nicotinic receptors in the rodent habenula. J Neurochem 2012; 121: 551– 560. 22380605 PMC3350326
- [37]Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ. Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci 2012; 32: 2352– 2356. 22396410 PMC3742968
- [38]Kravitz AV, Tye LD, Kreitzer AC. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 2012; 15: 816– 818. 22544310 PMC3410042
- [39]Kitai S, Shepard P, Callaway J, Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 1999; 9: 1– 8. 10607649
- [40]Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 2000; 27: 349– 357. 10985354
Cited by
Sorted by citations
Dopaminergic dynamics underlying sex-specific cocaine reward
Calipari, E. S., Juarez, B., Morel, C., Walker, D. M., Cahill, M. E., Ribeiro, E., Roman-Ortiz, C., Ramakrishnan, C., Deisseroth, K., Han, M.-H., et al. (2017) · Nature Communications · doi:10.1038/ncomms13877 · Cited by 359 · see citing works
Self-citationMcLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works
“The impact of the mutation that defines the risk allele has been validated repeatedly in vitro and in animal models (Kuryatov et al. 2011; Morel et al. 2014).”
BackgroundSelf-citationThe role of the habenula in drug addiction
Velasquez, K. M., Molfese, D. L., & Salas, R. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00174 · Cited by 155 · see citing works
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety
Nguyen, C., Mondoloni, S., Le Borgne, T., Centeno, I., Come, M., Jehl, J., Solié, C., Reynolds, L. M., Durand-de Cuttoli, R., Tolu, S., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.013 · Cited by 136 · see citing works
Self-citationRole of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125 · see citing works
Self-citationA CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans
Jensen, K. P., DeVito, E. E., Herman, A. I., Valentine, G. W., Gelernter, J., & Sofuoglu, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.131 · Cited by 85 · see citing works
A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine
Eddine, R., Valverde, S., Tolu, S., Dautan, D., Hay, A., Morel, C., Cui, Y., Lambolez, B., Venance, L., Marti, F., et al. (2015) · Scientific Reports · doi:10.1038/srep08184 · Cited by 42 · see citing works
“Importantly, the dose of nicotine injected is physiologically relevant as it corresponds to the dose that is intravenously self-administered by mice 19 .”
Self-citationNicotinic alteration of decision-making
Naudé, J., Dongelmans, M., & Faure, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.021 · Cited by 39 · see citing works
Teichman, E. M., Hu, J., Lin, H.-Y., Fisher-Foye, R. L., Blando, A., Hu, X., Kaniskan, H. Ü., Montgomery, S. E., Cai, M., Parise, L. F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02972-8 · Cited by 5 · see citing works
Self-citation
- Authors
- Morel, C., Fattore, L., Pons, S., Hay, Y. A., Marti, F., Lambolez, B., De Biasi, M., Lathrop, M., Fratta, W., Maskos, U., & Faure, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- National Research Council (IT)
- Fondation Jean Dausset-CEPH (FR)
- University of Cagliari (IT)
- Corresponding author
- Maskos, U
- Venue
- Molecular Psychiatry
- Published
- 2013-12-03
- Volume
- 19
- Issue
- 8
- Pages
- 930-936
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC8596967
- OpenAlex
- W2010762896
- Cited by
- 123
- References
- 8
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 8 · 2019: 11 · 2018: 17 · 2017: 11 · 2016: 13 · 2015: 17 · 2014: 8
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- National Institute on Drug Abuse (R21DA029157, DA029157)
- National Cancer Institute (U19CA148127)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine self-administration, nicotinic acetylcholine receptors, CHRNA5, dopaminergic neurons, ventral tegmental area, nicotine reinforcement, rs16969968, single nucleotide polymorphisms, loss-of-function mutations, tobacco dependence, nicotine sensitivity
- MeSH terms
- Action Potentials, Animals, Male, Nicotine, Receptors, Nicotinic, Reinforcement, Psychology, Self Administration, Ventral Tegmental Area, Mice, Knockout, Polymorphism, Single Nucleotide, Mice, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review